Morgan Stanley analyst Adahna Ekoku lowered the firm’s price target on Aperam (APEMY) to EUR 30.10 from EUR 30.30 and keeps an Equal Weight rating on the shares.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APEMY:
- Aperam price target raised to EUR 34 from EUR 29 at Citi
- Aperam upgraded to Neutral from Underweight at JPMorgan
- Aperam price target raised to EUR 30.30 from EUR 30 at Morgan Stanley
- Aperam SA (APEMY) Reveals Q1 Dividend: Here’s the Essential Information
- Aperam price target lowered to EUR 27 from EUR 28 at Barclays